Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals

Patent 8299102 was granted and assigned to Sanofi on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Sanofi

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82991020

Patent Inventor Names

Hartmut Strobel0

David William Will0

Gerhard Zoller0

Paulus Wohlfart0

Date of Patent

October 30, 2012

Patent Application Number

124861180

Date Filed

June 17, 2009

Patent Citations Received

‌

US Patent 11945794 Nuclear transport modulators and uses thereof

‌

US Patent 11746102 Polymorphs of selinexor

‌

US Patent 11753401 Polymorphs of Selinexor

‌

US Patent 11787771 Hydrazide containing nuclear transport modulators and uses thereof

Patent Primary Examiner

‌

Zinna Northington Davis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API